GlassScriptPhysician profile
Srinivas Bontha
NPI 1770676405
$5,529.82
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,468 · 2020: $71.66 · 2021: $404 · 2022: $1,262 · 2023: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $521.65 | 2019-2023 | |
| Amgen INC. | $497.95 | 2019-2022 | |
| Lilly USA, LLC | $484.19 | 2019-2023 | Lyumjev, Baqsimi, Jardiance |
| Novo Nordisk INC | $419.89 | 2019-2023 | Rybelsus, Ozempic |
| Abbott Laboratories | $279.83 | 2019-2023 | Freestyle Libre 3 |
| Mannkind Corporation | $229.79 | 2019-2021 | |
| Insulet Corporation | $222.45 | 2019 | |
| Xeris Pharmaceuticals, INC. | $204.32 | 2021-2023 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.94 | 2019-2023 | Jardiance |
| Abbvie INC. | $195.24 | 2019-2022 | |
| Radius Health, INC. | $190.86 | 2019-2023 | Tymlos |
| Merck Sharp & Dohme LLC | $176.43 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $171.26 | 2019-2022 | |
| Antares Pharma, INC. | $162.85 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $156.39 | 2019-2023 | Unithroid |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $151.91 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.93 | 2019 | |
| Corcept Therapeutics | $109.61 | 2019 | |
| Dexcom, INC. | $101.17 | 2019-2022 | |
| Shire North American Group INC | $99.68 | 2019 | |
| Ibsa Pharma INC. | $97.37 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.42 | 2022 | |
| Amarin Pharma, INC. | $81.53 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $73.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.16 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $48.51 | 2022 | |
| Kyowa Kirin, INC. | $47.30 | 2022 | |
| Amryt Pharma Holdings LTD | $40.49 | 2022 | |
| Pfizer INC. | $38.34 | 2019-2022 | |
| Valeritas, INC. | $37.48 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $36.83 | 2019 | |
| Companion Medical, INC. | $31.51 | 2019 | |
| Endo Pharmaceuticals INC. | $31.30 | 2019 | |
| Zealand Pharma US, INC. | $25.58 | 2022 | |
| Acerus Pharmaceuticals Corporation | $16.65 | 2022 | |
| Medtronic Minimed, INC. | $15.83 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $13.88 | 2019 | |
| Cequr Corporation | $13.87 | 2022 | |
| Vivus LLC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Bontha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.